A guided tour through α-helical peptide antibiotics and their targets

• Published in: Bioscience reports Vol. 43; no. 5; p. 1
• Main Authors: Preußke, Nils, Sönnichsen, Frank Dieter, Leippe, Matthias
• Format: Journal Article
• Language: English
• Published: England Portland Press Ltd The Biochemical Society 01-05-2023
• Subjects: Animal husbandry; Antibiotics; Antimicrobial activity; Antimicrobial agents; Antimicrobial peptides; Bacteria; Bacterial infections; Biofilms; Cell envelopes; Design; Effluents; Lipids; Membranes; Pathogens; Penicillin; Peptide antibiotics; Peptides; Plasma; Proteins; Ribonucleic acid; RNA; membrane disruption; bacteria; cell envelope; antimicrobial peptides; host defence peptides; biofilm
• ISSN: 0144-8463; 1573-4935
• DOI: 10.1042/BSR20230474

Nowadays, not only biologists, but also researchers from other disciplines such as chemistry, pharmacy, material sciences, or physics are working with antimicrobial peptides. This review is written for researchers and students working in or interested in the field of antimicrobial peptides - and especially those who do not have a profound biological background. To lay the ground for a thorough discussion on how AMPs act on cells, the architectures of mammalian and bacterial cell envelopes are described in detail because they are important targets of AMPs and provide the basis for their selectivity. The modes of action of α-helical AMPs (αAMPs) are not limited to different models of membrane permeabilization, but also include the disruption of intracellular processes, as well as the formation of fibrillary structures and their potential implications for antimicrobial activity. As biofilm-related infections are very difficult to treat with conventional antibiotics, they pose a major problem in the clinic. Therefore, this review also discusses the biological background of biofilm infections and the mode of actions of αAMPs against biofilms. The last chapter focusses on the design of αAMPs by providing an overview of historic milestones in αAMP design. It describes how modern αAMP design is aiming to produce peptides suitable to be applied in the clinic. Hence, the article concludes with a section on translational research discussing the prospects of αAMPs and remaining challenges on their way into the clinic.